Cellebrite announces redemption of all outstanding warrants

Cellebrite DI will redeem all of its warrants to purchase ordinary shares of the Company that remain outstanding at 5:00 p.m. New York City time on September 16, 2024 for a redemption price of $0.10 per Warrant. The Warrants include the outstanding public warrants to purchase Ordinary Shares issued pursuant to that certain Assignment, Assumption and Amended and Restated Warrant Agreement, dated on August 30, 2021, between the Company and Equiniti Trust Company, which were originally issued by TWC Tech Holdings II Corp. in connection with its initial public offering and subsequently assumed by the Company and converted into warrants to purchase Ordinary Shares of the Company as a result of the Company’s business combination with TWC which was consummated on August 30, 2021 for a redemption price of $0.10 per Public Warrant and the outstanding private placement warrants to purchase Ordinary Shares originally issued by TWC in a private placement transaction under the Private Placement Warrants Purchase Agreement, dated as of September 10, 2020, by and between TWC and TWC Tech Holdings II, LLC, and converted into warrants to purchase Ordinary Shares of the Company as a result of the Business Combination, on the same terms as the outstanding Public Warrants. Equiniti serves as warrant agent with respect to the Warrants.